2025年　英文

原著

  1. Ishiwada N, Nishi J, Fujimaki K, Takahashi S, Matsumoto T, Sato J, Watanabe M, Kakuya F, Oikawa J, Mori T, Takayanagi R, Yamaguchi Y, Hoshino T, Shinjoh M, Miyashita H, Tajima T, Funakoshi H, Narabayashi A, Oishi T, Okano R, Okada T, Furuno K, Tanaka Y, Ishii S, Yamatou T. Nationwide surveillance of bacterial pathogens isolated from children by the surveillance committee of the Japanese society of chemotherapy, Japanese association for infectious diseases, and Japanese society for clinical microbiology between April 2021 and March 2024: General overview of pathogenic antimicrobial susceptibility. Journal of Infection and Chemotherapy. 2025 Oct;31(10):102812.
  2. Kato M, Okamoto Y, Imamura T, Kada A, Saito A, Iijima-Yamashita Y, Deguchi T, Ohki K, Fukushima T, Anami K, Sanada M, Taki T, Hashii Y, Inukai T, Kiyokawa N, Kosaka Y, Yoshida N, Yuza Y, Yanagimachi M, Watanabe K, Sato A, Imai C, Taga T, Adachi S, Horibe K, Manabe A, Koh K. JCCG ALL-B12: Evaluation of Intensified Therapies With Vincristine/Dexamethasone Pulses and Asparaginase and Augmented High-Dose Methotrexate for Pediatric B-ALL. J Clin Oncol. 2025 Feb 10;43(5):567-577.
  3. Kawamura J, Takahashi Y, Nakae K, Ueno K, Tazaki Y, Ikeda T, Okamoto Y. Infantile scimitar syndrome with severe pulmonary hypertension with novel 3p26 microdeletion/12q23–24 microduplication: Case report and literature review. Progress in Pediatric Cardiology. 2025 March;76:101768.
  4. Kawamura J, Yamakuchi M, Ueno K, Hashiguchi T, Okamoto Y. MiR-25-3p regulates pulmonary arteriovenous malformation after Glenn procedure in patients with univentricular heart via the PHLPP2-HIF-1α axis. Scientific Reports. 2025 Feb;15(1):4138.
  5. Kawamura J, Yasukochi S, Takigiku K, Takei K, Saikawa Y, Nishiyama T, Tanaka T, Okada T. Quantification of Pulmonary Regurgitation After Surgical Repair of Tetralogy of Fallot Using Vector Flow Mapping. Circulation Journal.  2025 Aug;89(9):1510-1518.
  6. Kawano T, Sugita K, Masuya R, Nishida N, Nagano A, Murakami M, Yano K, Onishi S, Harumatsu T, Nakamura T, Yamada K, Yamada W, Muto M, Kodama Y, Nishikawa T, Kaji T, Okamoto Y, Ieiri S. A Retrospective Review of 28 Cases of Pediatric Malignant Renal Tumors at a Single Institution.  Diseases. 2025  Jan ;13(2):40
  7. Komaki H, Takeshita E, Kunitake K, Ishizuka T, Shimizu-Motohashi Y, Ishiyama A, Sasaki M, Yonee C, Maruyama S, Hida E, Aoki Y. Phase 1/2 trial of brogidirsen: Dual-targeting antisense oligonucleotides for exon 44 skipping in Duchenne muscular dystrophy. Cell Rep Med. 2025 Jan;6(1):101901.
  8. Miyamae T, Okamoto N, Inoue Y, Kubota T, Ebato T, Irabu H, Kameda H, Kaneko Y, Kubo H, Mitsunaga K, Mori M, Nakajima A, Nishimura K, Ohkubo N, Sato T, Sugita Y, Takanashi S, Tanaka T, Umebayashi H, Yashiro M, Yamanishi S, Fusama M, Hirata S, Kishimoto M, Kohno M, Kojima M, Kojima T, Morinobu A, Sugihara T, Tanaka E, Yajima N, Yanai R, Kawahito Y, Harigai M. Recommendations for the Treatment of Juvenile Idiopathic Arthritis with Oligoarthritis or Polyarthritis from the 2024 update of the Japan College of Rheumatology Clinical Practice Guidelines for the management of Rheumatoid Arthritis including Juvenile Idiopathic Arthritis with Oligoarthritis or Polyarthritis- Secondary Publication. Modern Rheumatology. 2025 Jun 3:roaf042. doi: 10.1093/mr/roaf042. Online ahead of print.
  9. Morimoto M, Nishikawa T, Hijikata A, Kasabata H, Maeda N, Kanmura S, Horikawa S, Nagahama J, Nakamura A, Nakamura T, Abematsu T, Nakagawa S, Shimura K, Narumi S, Kanegane H and Okamoto Y. GATA2 deficiency in two families with novel frameshift variants highlighting phenotypic diversity and need for early diagnosis. Front. Immunol. 2025 Jul:16:1644552.
  10. Nakamura T, Nakagawa S, Horikawa S, Nagahama J, Yasudome Y, Abematsu T, Kodama Y, Nishikawa T, Okamoto Y. Safety and efficacy of sedation for pediatric patients with cancer and developmental disabilities. Pediatr Int. 2025 Jan-Dec;67(1):e70142.
  11. Nakamura T, Nakagawa S, Kodama Y, Abematsu T, Nishikawa T, Okamoto Y. Central neurogenic hyperventilation throughout radiotherapy in a pediatric patient with diffuse intrinsic pontine glioma. Pediatr Int.  2025 Jan-Dec;67(1):e70182
  12. Nishikawa T, Tomomasa D, Hijikata A, Kasabata H, Okamoto Y, Ochs HD and Kanegane H (2025) Case Report: CD40LG Arg203Ile variant underlies atypical phenotype of X-linked hyper IgM syndrome. Front. Immunol. 2025 May;16:1572791.
  13. Seki Y, Kakimoto H, Tamada I, Oku S, Morita S, Tokunaga M, Mizota M, Amano N, Uchida N, Hasegawa T, Okamoto Y. Phenotypic variation among four members in a family with DAX1 deficiency. Journal of Pediatric Endocrinology and Metabolism. 2025 Jul.
    doi: 10.1515/jpem-2025-0063. Online ahead of print.
  14. Shimizu T, Kawamura J, Maruyama S, Ueno K, Okamoto Y. Resolution of brady- and tachyarrhythmias with everolimus in a child with tuberous sclerosis complex: A case report. Pediatr Int. 2025 Jan-Dec;67(1):e70264.
  15. Shiokawa N, Kawamura J, Ueno K, Okamoto Y. Coronary ostial stenosis in an infant with nonischemic anomalous left coronary artery from the pulmonary artery. Ann Pediatr Card. 2025 Jan-Feb;18(1):79-80.
  16. Uenohara R, Ueno K, Hamada S, Nakamura A, Takahashi Y, Kawamura J, Okamoto Y. A case of post-Fontan syndrome with paroxysmal sympathetic hyperactivity following subgaleal hematoma. Pediatr Int. 2025 Jan-Dec;67(1):e70206.
  17. Yamanaka S, Hanada T, Higashi T, Matsunaga M, Yonee C, Maruyama S, Hanaya R. Intrathecal Baclofen Therapy Improves Refractory Status Dystonicus in Neuro-hepatic Wilson’s Disease: A Case Report. NMC Case Rep J. 2025 Apr;12:91-95.

総説

  1. Tokunaga M, Seki Y, Horiguchi T, Miura K, Kakimoto H, Morita S, Mizota M, Kusumoto K, Mori T, Sohara E, Uchida S, Okamoto Y. A parent and child with Liddle syndrome diagnosed correctly with the child as the proband: a case report with review of literature. Endocrine Journal. 2025 Mar;72(3):319-323.